Often, therapeutic development has focused on tiny agents, but amino acid alliances are increasingly receiving attention. This innovative methodology embraces combining peptidic sequences with alternative therapeutic modalities to confront intricate illness targets. By leveraging the unique features of amino acid sequences – such as significant p